Koustav Chatterjee

Clinical Insights — United States

Medicine · Health Sciences

10h-index418citations38works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(17), Neurological disorders and treatments(17), Botulinum Toxin and Related Neurological Disorders(6), Vagus Nerve Stimulation Research(6), Genetic Neurodegenerative Diseases(5)

Publications38 total

RWD185 Trends and Disparities in Prostate Cancer Incidence Prevalence and Survival: A SEER Analysis 2000-2022
Value in Health·2025
MSR78 Drifting in the Network: Catching Baseline Shifts Before They Wreck Your Network Meta-Analysis
Value in Health·2025
703 Shifting landscapes: impact of first-line immuno-oncology therapy on second-line docetaxel treatment in metastatic NSCLC
Regular and Young Investigator Award Abstracts·2024Open Access
Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic Cells
The Journal of Immunology·2024· 2 cited
Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease
Frontiers in Aging Neuroscience·2024· 13 citedOpen Access
Genetic Variations and Altered Blood mRNA Level of Circadian Genes and BDNF as Risk Factors of Post-Stroke Cognitive Impairment Among Eastern Indians
NeuroMolecular Medicine·2023· 7 cited
Effect of Non-Invasive Vagus Nerve Stimulation in Clinical and Molecular Biomarkers of Parkinson’s Disease
Research Square (Research Square)·2023Open Access
Characterizing gait and exploring neuro-morphometry in patients with PSP-Richardson's syndrome and vascular parkinsonism
Parkinsonism & Related Disorders·2023· 7 cited
Retraction Note: Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
npj Parkinson s Disease·2022· 3 citedOpen Access
Think of <scp>SCA45</scp> in Late‐Onset Familial Ataxias: The First Report from the Indian Subcontinent with a Novel Variant
Movement Disorders Clinical Practice·2022· 1 citedOpen Access
Is peripheral alpha synuclein a marker for gait velocity in Parkinson’s disease?
Neuroscience Letters·2022· 5 cited
Novel inflammasome and oxidative modulators in Parkinson’s disease: A prospective study
Neuroscience Letters·2022· 20 cited
The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia
Epilepsia Open·2021· 7 citedOpen Access
Clinical Significance of Applause Sign in Patients with Progressive Supranuclear Palsy
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques·2021· 3 citedOpen Access
Semantic Fluency Predicts Gait Velocity in PSP
Annals of Indian Academy of Neurology·2021· 8 citedOpen Access
RETRACTED ARTICLE: Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
npj Parkinson s Disease·2021· 34 citedOpen Access
Do peripheral immune and neurotrophic markers correlate with motor severity of Parkinson's disease?
Journal of Neuroimmunology·2021· 9 cited
A longitudinal quantitative analysis of gait in patients with SCA-12
Clinical Parkinsonism & Related Disorders·2021· 4 citedOpen Access
Relevance of Subtype Classification of PSP
Annals of Indian Academy of Neurology·2021Open Access
Blood α-synuclein level as a potential peripheral marker of Parkinson's disease phenotype
Parkinsonism & Related Disorders·2020
page 1 of 2Next →

Frequent Co-authors

Supriyo Choudhury(28), Hrishikesh Kumar(28), Banashree Mondal(22), Rebecca Banerjee(17), Akash Roy(14), Purba Basu(14), Shantanu Shubham(9), Stuart N. Baker(8), Mark R. Baker(8), Saptak Halder(7), Ravi Singh(6), Sanjit Dey(4), Marium Umme Kulsum(3), Arijit Roy(3), Saswata Paul Choudhury(3), Sekhar Kumar Dutta(3), Sayan Chatterjee(2), Sidharth Shankar Anand(2), Santosh Trivedi(2), Payel Chatterjee(2)